← Back
$COLL All transactions

COLLEGIUM PHARMACEUTICAL, INC

F

$ Value

$539K

Shares

11,538

Price

$47

Filed

Feb 12

Insider

Name

Smith Thomas B

Title

EVP and Chief Medical Officer

CIK

0001748462

Roles

Officer

Transaction Details

Transaction Date

2026-02-10

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

90,651

Footnotes

Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. | Includes 376 and 404 shares acquired on July 18, 2025 and January 16, 2026, respectively, under the Issuer's employee stock purchase plan. | Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,774 performance share units ("PSUs") granted in the Issuer's three prior fiscal years. | Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. | Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Filing Info

Accession No.

0001748462-26-000002

Form Type

4

Issuer CIK

0001267565

Smith Thomas B's History

Date Ticker Type Value
2026-02-10 COLL A $0
2026-02-10 COLL A $0
2026-02-10 COLL F $276K
2026-02-10 COLL F $539K
2025-08-29 COLL $672K

Other Insiders at COLL (90d)

Insider Bought Sold Last
Karnani Vikram
President and CEO
2026-02-10
Dreyer Scott
EVP & Chief Commercial Officer
$2.0M 2026-03-03
Smith Thomas B
EVP and Chief Medical Officer
2026-02-10
Tupper Colleen
EVP & Chief Financial Officer
2026-02-10
Dieter David
EVP & General Counsel
2026-03-17